Unlock this StockReport nowClick to Unlock

Scandinavian ChemoTech AB Share Price

CMOTEC B SEK12.45 -0.2  -1.2%

Relative Strength (%)
Volume Change (%)
10d v 3m
Price vs... (%)
52w High
50d MA
200d MA
Growth & Value
Margin of Safety (beta)
Screens Passed
Balance Sheet · Income Statement · Cashflow Financial Summary
Year End 31st Dec 2013 2014 2015 2016 2017 2018 2019E 2020E CAGR / Avg
Revenue SEKm
Operating Profit SEKm
Net Profit SEKm
EPS Reported SEK
EPS Normalised SEK
EPS Growth %
PE Ratio x
Operating Margin %
Op. Cashflow ps SEK
Capex ps SEK
Free Cashflow ps SEK
Dividend ps SEK
Dividend Growth %
Dividend Yield %
Dividend Cover x
Balance Sheet
Cash etc SEKm
Working Capital SEKm
Net Fixed Assets SEKm
Net Debt SEKm
Book Value SEKm
Average Shares m
Book Value ps SEK +474.1%

FINANCIAL BRIEF: For the fiscal year ended 31 December 2018, Scandinavian ChemoTech AB revenues increased from SEK41K to SEK560K. Net loss decreased 61% to SEK4.8M. Revenues reflect an increase in demand for the Company's products and services due to favorable market conditions. Lower net loss reflects Other External Expenses decrease of 47% to SEK6.6M (expense), Personnel costs decrease of 60% to SEK1.2M (expense). more »

Health Trend
Bankruptcy Risk
  Earnings Manipulation Risk
Magic Formula Score  
Other Ratios
Leverage (ttm) Total -Intang +Pension
Gross Gearing %
Net Gearing %
Cash / Assets %
Recent History
Latest interim period (ended 31st Dec '18) vs. prior year
Sales Growth %
EPS Growth %
3yr Compound Annual Growth Rate
Sales Growth %
EPS Growth %
DPS Growth %

Broker Forecasts
31st Dec 2019
31st Dec 2020

Price Target: N/A
Net Profit EPS DPS Net Profit EPS DPS
Est. Long Term Growth Rate: n/a () () () () () ()
Consensus Estimate
1m Change
3m Change
Broker Consensus Trend
Broker Recommendations for Scandinavian ChemoTech AB
Recommendation:Strong SellSellHoldBuyStrong Buy
No. of Analysts:

Named Brokers and Analysts
There are no named brokers.

Profile Summary

Scandinavian ChemoTech AB is a Sweden-based company, which is primarily engaged in the healthcare industry. The Company is focused on cancer treatment and manufactures specialized medical equipment. The Company's product IQWave is an electrochemotherapy (ECT) device. The IQWave system enhances the effects of the chemotherapeutic substance by opening up small pores in the tumor cells, giving the injected chemotherapeutic substance (no more than 15 IU of bleomycin) direct access to the DNA of the target cells. Among the product's applications are hypernephroma, kaposi sarcoma, transitional cell carcinoma, head and neck squamous cell carcinoma, malignant melanoma, basal cell carcinoma. The treatment can be used for cutaneous as well as subcutaneous tumors.

Directors: Ingalill Forslund Larsson (CHM) 65, Stefan Frick (CEO) 43, Arne Bojesson (CFO) 68, Bertil Persson (VRD) , Johan Marnfeldt (OTH) , Goran Hellers (DRC) 72, Johan Wennerholm (DRC) 51,

No. of Employees: n/a No. of Shareholders: n/a

Last Annual December 31st, 2018
Last Interim December 31st, 2018
Public Since December 6, 2016
Shares in Issue 2,925,000
Free Float 2.45m (83.8%)
Sector Healthcare
Industry Healthcare Equipment & Supplies
Exchange OMX Nordic Exchange Stockholm
Eligible for an ISA? a SIPP?

CMOTEC B Share Price Performance CMOTEC B Share Price Quote
-0.2  -1.2%
Traded 5:00pm · Minimum 15 min delayed · NMS:

Use of our data service is subject to express Terms of Service. Please see our full site disclaimer for more details. In particular, it is very important to do your own research (DYOR) and seek professional advice before making any investment based on your own personal circumstances. Please note that the information, data and analysis contained within this stock report: (a) include the proprietary information of Stockopedia's third party licensors and Stockopedia; (b) should not be copied or redistributed except as specifically authorised; and (c) are not warranted to be complete, accurate or timely. You should independently research and verify any information that you find in this report. Stockopedia will not be liable in respect of any loss, trading or otherwise, that you may suffer arising out of such information or any reliance you may place upon it. Past performance is no guarantee of future results. The value and income derived from investments may go down as well as up. © Stockopedia 2019.

Should you buy CMOTEC B

Access CMOTEC B Analytics Now!

Let’s get you setup so you get the most out of our service
Done, Let's add some stocks
Brilliant - You've created a folio! Now let's add some stocks to it.

  • Apple (AAPL)

  • Shell (RDSA)

  • Twitter (TWTR)

  • Volkswagon AG (VOK)

  • McDonalds (MCD)

  • Vodafone (VOD)

  • Barratt Homes (BDEV)

  • Microsoft (MSFT)

  • Tesco (TSCO)
Save and show me my analysis